Zota Health Care LImited — Updates, 15-11-2024: Press Release

Zota Health Care Limited reported a robust performance for Q2FY25, highlighting 48.6% year-on-year revenue growth, with total revenues reaching ₹6,728 crores. Gross profit surged by 76.4% to ₹3,602 crores, reflecting strong demand for its pharmaceutical products. The company's expansion strategy is evident, having added 133 new Davaindia stores, bringing the total to 1,165 locations. Quarterly footfall increased significantly from 12.22 lakh in Q2FY24 to 22.23 lakh in Q2FY25, underscoring the growing market presence. The Gross Merchandise Value (GMV) nearly doubled, rising from ₹3,159 lakhs to ₹5,554 lakhs, indicating increased consumer engagement. With a strengthened nationwide presence, Zota aims to address diverse healthcare needs and solidify its position in the competitive generic retail pharmacy sector.

Investors should view this growth trajectory positively, as Zota appears well-positioned for continued expansion and profitability in a growing market.